COVID-19导致了医疗保健的混乱，特别是癌症筛查方面。我们工作的主要目的是评估人群对基于家庭的结直肠癌（CRC）和宫颈癌（原发性HPV测试）筛查的接受度。通过门诊电子病历，确认了三组成人具有不同健康负担，可能影响他们接受基于家庭癌症筛查的接受度，包括以下情况：曾经在COVID住院过、呼吸系统非COVID阳性和患有2型糖尿病。132名受访者（58％女性）完成了有关他们接受基于家庭CRC或宫颈癌筛查的虚拟案例的在线调查。在女性中，64％和59％的人分别接受了原发性HPV测试的尿液和阴道筛查。在男性和女性中，使用粪便免疫化学试剂测试（FIT）或Cologuard的家庭CRC筛查对60％的受访者来说是可接受的。在调整了教育水平后，对家庭尿液/阴道筛查持积极态度的女性相对于CRC筛查的积极态度分别为49倍和23倍（aOR = 48.7（95％CI：7.1, 337）和aOR = 23.2（95％CI：3.8, 142））。此报告表明，基于家庭的CRC和原发性HPV测试癌症筛查对男性和女性是可接受的，并且可以为将来更好地遵守筛查提供便利。2021年家庭医学年鉴公司。

COVID-19 has caused disruptions in health care, in particular cancer screenings. The primary aim of our work was to evaluate the degree to which populations were accepting of home-based screenings for colorectal cancer (CRC) and cervical cancer (primary HPV testing). Three groups of adults having distinct health burdens which may affect acceptance of home-based cancer screening were identified through outpatient electronic medical records as follows as either having survived a COVID hospitalization, having been positive for non-COVID respiratory illness or having type 2 diabetes. 132 respondents (58% female) completed an online survey with hypothetical cases about their acceptance of home-based CRC or cervical cancer screening. Among females, urine and vaginal screening for primary HPV testing was acceptable to 64% and 59%, respectively. Among both males and females, CRC home screening with fecal immunochemical test (FIT) or Cologuard was acceptable to 60% of the respondents. When adjusting for education, women with a positive attitude toward home-based urine /vaginal screening were 49 times and 23 times more likely to have a positive attitude toward CRC screening (aOR=48.7 (95% CI: 7.1, 337) and aOR=23.2 (95% CI: 3.8, 142), respectively). This report indicates that home-based cancer screens for CRC and primary HPV testing are acceptable to men and women and may allow for greater compliance with screening in the future.2021 Annals of Family Medicine, Inc.